Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montague, C. T.
Right arrow Articles by O'Rahilly, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montague, C. T.
Right arrow Articles by O'Rahilly, S.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 6 883-888, Copyright © 2000 by American Diabetes Association

ARTICLES

The perils of portliness: causes and consequences of visceral adiposity

CT Montague and S O'Rahilly
Cardiovascular and Gastrointestinal Discovery Research Department, AstraZeneca Pharmaceuticals, Macclesfield, UK. carl.montague@astrazeneca.com

Although an individual's total fat mass predicts morbidities such as coronary artery disease and diabetes, the anatomical distribution of adipose tissue is a strong and independent predictor of such adverse health outcomes. Thus, obese individuals with most of their fat stored in visceral adipose depots generally suffer greater adverse metabolic consequences than similarly overweight subjects with fat stored predominantly in subcutaneous sites. A fuller understanding of the biology of central obesity will require information regarding the genetic and environmental determinants of human fat topography and of the molecular mechanisms linking visceral adiposity to degenerative metabolic and vascular disease. Here we attempt to summarize the growing body of data relevant to these key areas and, in particular, to illustrate how recent advances in adipocyte biology are providing the basis for new pathophysiological insights.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DevelopmentHome page
N. Billon, P. Iannarelli, M. C. Monteiro, C. Glavieux-Pardanaud, W. D. Richardson, N. Kessaris, C. Dani, and E. Dupin
The generation of adipocytes by the neural crest
Development, June 15, 2007; 134(12): 2283 - 2292.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
L. P Hunt, A. Ford, M. A Sabin, E. C Crowne, and J. P H Shield
Clinical measures of adiposity and percentage fat loss: which measure most accurately reflects fat loss and what should we aim for?
Arch. Dis. Child., May 1, 2007; 92(5): 399 - 403.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Fontana, J. C. Eagon, M. E. Trujillo, P. E. Scherer, and S. Klein
Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans
Diabetes, April 1, 2007; 56(4): 1010 - 1013.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. W Demerath, W. Shen, M. Lee, A. C Choh, S. A Czerwinski, R. M Siervogel, and B. Towne
Approximation of total visceral adipose tissue with a single magnetic resonance image
Am. J. Clinical Nutrition, February 1, 2007; 85(2): 362 - 368.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Suganami, K. Tanimoto-Koyama, J. Nishida, M. Itoh, X. Yuan, S. Mizuarai, H. Kotani, S. Yamaoka, K. Miyake, S. Aoe, et al.
Role of the Toll-like Receptor 4/NF-{kappa}B Pathway in Saturated Fatty Acid-Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 84 - 91.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. C. Hannukainen, P. Nuutila, B. Ronald, J. Kaprio, U. M. Kujala, T. Janatuinen, O. J. Heinonen, J. Kapanen, T. Viljanen, M. Haaparanta, et al.
Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins
J. Physiol., January 1, 2007; 578(1): 347 - 358.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. M. Kindblom, M. Lorentzon, E. Norjavaara, L. Lonn, J. Brandberg, J.-E. Angelhed, A. Hellqvist, S. Nilsson, and C. Ohlsson
Pubertal Timing Is an Independent Predictor of Central Adiposity in Young Adult Males: The Gothenburg Osteoporosis and Obesity Determinants Study
Diabetes, November 1, 2006; 55(11): 3047 - 3052.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. A. M. den Boer, P. J. Voshol, J. P. Schroder-van der Elst, E. Korsheninnikova, D. M. Ouwens, F. Kuipers, L. M. Havekes, and J. A. Romijn
Endogenous Interleukin-10 Protects against Hepatic Steatosis but Does Not Improve Insulin Sensitivity during High-Fat Feeding in Mice
Endocrinology, October 1, 2006; 147(10): 4553 - 4558.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. M. Kanaya, C. Wassel Fyr, E. Vittinghoff, T. B. Harris, S. W. Park, B. H. Goodpaster, F. Tylavsky, and S. R. Cummings
Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.
Arch Intern Med, February 13, 2006; 166(3): 350 - 356.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. R. Hoffman, B. M. K. Biller, D. Cook, J. Baptista, B. L. Silverman, L. Dao, K. M. Attie, P. Fielder, T. Maneatis, B. Lippe, et al.
Efficacy of a Long-Acting Growth Hormone (GH) Preparation in Patients with Adult GH Deficiency
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6431 - 6440.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
E. Parker, D. I. W. Phillips, R. A. Cockington, C. Cull, and J. Poulton
A common mitchondrial DNA variant is associated with thinness in mothers and their 20-yr-old offspring
Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1110 - E1114.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
N. M. Punjabi and V. Y. Polotsky
Disorders of glucose metabolism in sleep apnea
J Appl Physiol, November 1, 2005; 99(5): 1998 - 2007.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Suganami, J. Nishida, and Y. Ogawa
A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor {alpha}
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2062 - 2068.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
H. E. Lebovitz and M. A. Banerji
Point: Visceral Adiposity Is Causally Related to Insulin Resistance
Diabetes Care, September 1, 2005; 28(9): 2322 - 2325.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. P. Goldstone, M. Patterson, N. Kalingag, M. A. Ghatei, A. E. Brynes, S. R. Bloom, A. B. Grossman, and M. Korbonits
Fasting and Postprandial Hyperghrelinemia in Prader-Willi Syndrome Is Partially Explained by Hypoinsulinemia, and Is Not Due to Peptide YY3-36 Deficiency or Seen in Hypothalamic Obesity Due to Craniopharyngioma
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2681 - 2690.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. R. Sinaiko, J. Steinberger, A. Moran, R. J. Prineas, B. Vessby, S. Basu, R. Tracy, and D. R. Jacobs Jr
Relation of Body Mass Index and Insulin Resistance to Cardiovascular Risk Factors, Inflammatory Factors, and Oxidative Stress During Adolescence
Circulation, April 19, 2005; 111(15): 1985 - 1991.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Sjoholm, J. Palming, L. E. Olofsson, A. Gummesson, P.-A. Svensson, T. C. Lystig, E. Jennische, J. Brandberg, J. S. Torgerson, B. Carlsson, et al.
A Microarray Search for Genes Predominantly Expressed in Human Omental Adipocytes: Adipose Tissue as a Major Production Site of Serum Amyloid A
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2233 - 2239.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Guan, E. Arany, J. P. van Beek, A. Chamson-Reig, S. Thyssen, D. J. Hill, and K. Yang
Adipose tissue gene expression profiling reveals distinct molecular pathways that define visceral adiposity in offspring of maternal protein-restricted rats
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E663 - E673.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. E. Duncan, S. M. Li, and X.-H. Zhou
Prevalence and Trends of a Metabolic Syndrome Phenotype Among U.S. Adolescents, 1999-2000
Diabetes Care, October 1, 2004; 27(10): 2438 - 2443.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Wiedmer, J. Zhao, L. Li, Q. Zhou, A. Hevener, J. M. Olefsky, L. K. Curtiss, and P. J. Sims
Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3)
PNAS, September 7, 2004; 101(36): 13296 - 13301.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Valsamakis, A. Anwar, J. W. Tomlinson, C. H. L. Shackleton, P. G. McTernan, R. Chetty, P. J. Wood, A. K. Banerjee, G. Holder, A. H. Barnett, et al.
11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity in Lean and Obese Males with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4755 - 4761.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
S. G. Glickman, C. S. Marn, M. A. Supiano, and D. R. Dengel
Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity
J Appl Physiol, August 1, 2004; 97(2): 509 - 514.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
U. Riserus, J. Arnlov, K. Brismar, B. Zethelius, L. Berglund, and B. Vessby
Sagittal Abdominal Diameter Is a Strong Anthropometric Marker of Insulin Resistance and Hyperproinsulinemia in Obese Men
Diabetes Care, August 1, 2004; 27(8): 2041 - 2046.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Haap, C. Thamer, H.-U. Haring, R. M. Szeimies, and M. Stumvoll
Multiple Symmetric Lipomatosis: A Paradigm of Metabolically Innocent Obesity?: Response to Harsch, Schahin, and Wiedmann
Diabetes Care, July 1, 2004; 27(7): 1850 - 1850.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Ten and N. Maclaren
Insulin Resistance Syndrome in Children
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2526 - 2539.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Lundgren, J. Buren, T. Ruge, T. Myrnas, and J. W. Eriksson
Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2989 - 2997.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. M. Paterson, N. M. Morton, C. Fievet, C. J. Kenyon, M. C. Holmes, B. Staels, J. R. Seckl, and J. J. Mullins
Metabolic syndrome without obesity: Hepatic overexpression of 11{beta}-hydroxysteroid dehydrogenase type 1 in transgenic mice
PNAS, May 4, 2004; 101(18): 7088 - 7093.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Giusti, M. Suter, C. Verdumo, R. C. Gaillard, P. Burckhardt, and F. P. Pralong
Molecular Determinants of Human Adipose Tissue: Differences between Visceral and Subcutaneous Compartments in Obese Women
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1379 - 1384.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Haap, C. Siewecke, C. Thamer, J. Machann, F. Schick, H.-U. Haring, R. M. Szeimies, and M. Stumvoll
Multiple Symmetric Lipomatosis: A paradigm of metabolically innocent obesity?
Diabetes Care, March 1, 2004; 27(3): 794 - 795.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
A. M. Kanaya, E. Vittinghoff, M. G. Shlipak, H. E. Resnick, M. Visser, D. Grady, and E. Barrett-Connor
Association of Total and Central Obesity with Mortality in Postmenopausal Women with Coronary Heart Disease
Am. J. Epidemiol., December 15, 2003; 158(12): 1161 - 1170.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Perseghin, G. Lattuada, M. Danna, L. P. Sereni, P. Maffi, F. De Cobelli, A. Battezzati, A. Secchi, A. Del Maschio, and L. Luzi
Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes
Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1174 - E1181.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. B. Davidson
Is Treatment of Insulin Resistance Beneficial Independent of Glycemia?
Diabetes Care, November 1, 2003; 26(11): 3184 - 3186.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. E. Gates, C. L. Gentile, D. R. Seals, and D. D. Christou
Adiposity Contributes to Differences in Left Ventricular Structure and Diastolic Function with Age in Healthy Men
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4884 - 4890.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. E. Kelley, T. M. McKolanis, R. A. F. Hegazi, L. H. Kuller, and S. C. Kalhan
Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E906 - E916.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. H. Knopp, B. Retzlaff, B. Fish, C. Walden, S. Wallick, M. Anderson, K. Aikawa, and S. E. Kahn
Effects of Insulin Resistance and Obesity on Lipoproteins and Sensitivity to Egg Feeding
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1437 - 1443.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. C. Christian, D. A. Dumesic, T. Behrenbeck, A. L. Oberg, P. F. Sheedy II, and L. A. Fitzpatrick
Prevalence and Predictors of Coronary Artery Calcification in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2562 - 2568.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. K. Gan, A. D. Kriketos, B. A. Ellis, C. H. Thompson, E. W. Kraegen, and D. J. Chisholm
Changes in Aerobic Capacity and Visceral Fat but not Myocyte Lipid Levels Predict Increased Insulin Action After Exercise in Overweight and Obese Men
Diabetes Care, June 1, 2003; 26(6): 1706 - 1713.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
X. Wu, H. Motoshima, K. Mahadev, T. J. Stalker, R. Scalia, and B. J. Goldstein
Involvement of AMP-Activated Protein Kinase in Glucose Uptake Stimulated by the Globular Domain of Adiponectin in Primary Rat Adipocytes
Diabetes, June 1, 2003; 52(6): 1355 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
R. P Stolk, R. Meijer, W. P. Mali, D. E Grobbee, and Y. van der Graaf
Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference
Am. J. Clinical Nutrition, April 1, 2003; 77(4): 857 - 860.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. E Sumner, N. M Farmer, M. K Tulloch-Reid, N. G Sebring, J. A Yanovski, J. C Reynolds, R. C Boston, and A. Premkumar
Sex differences in visceral adipose tissue volume among African Americans
Am. J. Clinical Nutrition, November 1, 2002; 76(5): 975 - 979.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Sewter, F. Blows, R. Considine, A. Vidal-Puig, and S. O'Rahilly
Differential Effects of Adiposity on Peroxisomal Proliferator-Activated Receptor {gamma}1 and {gamma}2 Messenger Ribonucleic Acid Expression in Human Adipocytes
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4203 - 4207.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Uusitupa
Lifestyles Matter in the Prevention of Type 2 Diabetes
Diabetes Care, September 1, 2002; 25(9): 1650 - 1651.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Perseghin, P. Scifo, M. Danna, A. Battezzati, S. Benedini, E. Meneghini, A. Del Maschio, and L. Luzi
Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation
Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E556 - E564.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
J D Tugwood and C T Montague
Biology and toxicology of PPARg ligands
Human and Experimental Toxicology, August 1, 2002; 21(8): 429 - 437.
[Abstract] [PDF]

Home page
 DiabetesHome page
M. Stumvoll and H. Haring
The Peroxisome Proliferator-Activated Receptor-{gamma}2 Pro12Ala Polymorphism
Diabetes, August 1, 2002; 51(8): 2341 - 2347.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. M. Stulnig, U. Oppermann, K. R. Steffensen, G. U. Schuster, and J.-A. Gustafsson
Liver X Receptors Downregulate 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
Diabetes, August 1, 2002; 51(8): 2426 - 2433.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Gagnon, K. J. Abaiian, T. Crapper, M. D. Layne, and A. Sorisky
Down-Regulation of Aortic Carboxypeptidase-Like Protein during the Early Phase of 3T3-L1 Adipogenesis
Endocrinology, July 1, 2002; 143(7): 2478 - 2485.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev., April 1, 2002; 23(2): 201 - 229.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. Takami, N. Takeda, K. Nakashima, R. Takami, M. Hayashi, S. Ozeki, A. Yamada, Y. Kokubo, M. Sato, S.-i. Kawachi, et al.
Effects of Dietary Treatment Alone or Diet With Voglibose or Glyburide on Abdominal Adipose Tissue and Metabolic Abnormalities in Patients With Newly Diagnosed Type 2 Diabetes
Diabetes Care, April 1, 2002; 25(4): 658 - 662.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. R. Greenfield, K. Samaras, and D. J. Chisholm
Insulin Resistance, Intra-Abdominal Fat, Cardiovascular Risk Factors, and Androgens in Healthy Young Women with Type 1 Diabetes Mellitus
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1036 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. Ek, P. Arner, M. Ryden, C. Holm, A. Thorne, J. Hoffstedt, and H. Wahrenberg
A Unique Defect in the Regulation of Visceral Fat Cell Lipolysis in the Polycystic Ovary Syndrome as an Early Link to Insulin Resistance
Diabetes, February 1, 2002; 51(2): 484 - 492.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
X. Wu, J. Hoffstedt, W. Deeb, R. Singh, N. Sedkova, A. Zilbering, L. Zhu, P. K. Park, P. Arner, and B. J. Goldstein
Depot-Specific Variation in Protein-Tyrosine Phosphatase Activities in Human Omental and Subcutaneous Adipose Tissue: A Potential Contribution to Differential Insulin Sensitivity
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5973 - 5980.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. E. Kelley, K. V. Williams, J. C. Price, T. M. McKolanis, B. H. Goodpaster, and F. L. Thaete
Plasma Fatty Acids, Adiposity, and Variance of Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5412 - 5419.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. A. Schreyer, D. E. Cummings, G. S. McKnight, and R. C. LeBoeuf
Mutation of the RII{beta} Subunit of Protein Kinase A Prevents Diet-Induced Insulin Resistance and Dyslipidemia in Mice
Diabetes, November 1, 2001; 50(11): 2555 - 2562.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. J. de Souza, M. Eckhardt, K. Gagen, M. Dong, W. Chen, D. Laurent, and B. F. Burkey
Effects of Pioglitazone on Adipose Tissue Remodeling Within the Setting of Obesity and Insulin Resistance
Diabetes, August 1, 2001; 50(8): 1863 - 1871.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Takami, N. Takeda, M. Hayashi, A. Sasaki, S. Kawachi, K. Yoshino, K. Takami, K. Nakashima, A. Akai, N. Yamakita, et al.
Body Fatness and Fat Distribution as Predictors of Metabolic Abnormalities and Early Carotid Atherosclerosis
Diabetes Care, July 1, 2001; 24(7): 1248 - 1252.
[Abstract] [Full Text] [PDF]

Home page